Since taking office in January 2025, the Trump Administration has announced, imposed, or reimposed various tariff-related restrictions on ...

The China pharmaceutical intermediate market is set for significant expansion, with a projected valuation of USD 9,309.7 million in 2025, growing at a CAGR of 6.4% to reach USD 17,276.3 million by ...

The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth ...

In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...